Theranostic strategy against plaque angiogenesis

JACC Cardiovasc Imaging. 2008 Sep;1(5):635-7. doi: 10.1016/j.jcmg.2008.07.007.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Angiogenesis Inhibitors / metabolism
  • Angiogenesis Inhibitors / pharmacology*
  • Animals
  • Atherosclerosis / drug therapy*
  • Atherosclerosis / metabolism
  • Atherosclerosis / pathology
  • Atorvastatin
  • Carbocyanines / metabolism
  • Cyclohexanes / metabolism
  • Cyclohexanes / pharmacology*
  • Drug Carriers
  • Drug Synergism
  • Drug Therapy, Combination
  • Fatty Acids, Unsaturated / metabolism
  • Fatty Acids, Unsaturated / pharmacology*
  • Heptanoic Acids / pharmacology
  • Heterocyclic Compounds, 1-Ring / metabolism
  • Humans
  • Integrin alphaVbeta3 / metabolism
  • Magnetic Resonance Imaging
  • Nanoparticles
  • Neovascularization, Pathologic / metabolism
  • Neovascularization, Pathologic / pathology
  • Neovascularization, Pathologic / prevention & control*
  • Pyrroles / pharmacology
  • Sesquiterpenes / metabolism
  • Sesquiterpenes / pharmacology
  • Time Factors

Substances

  • Angiogenesis Inhibitors
  • Carbocyanines
  • Cyclohexanes
  • Drug Carriers
  • Fatty Acids, Unsaturated
  • Heptanoic Acids
  • Heterocyclic Compounds, 1-Ring
  • Integrin alphaVbeta3
  • Pyrroles
  • Sesquiterpenes
  • TA 145
  • fumagillin
  • Atorvastatin